Vimarsana
Biggest News Aggregation in the World

Page 2 - Edge Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Edge Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Edge Pharma Today - Breaking & Trending Today

Can't Dismiss Lanham Act Claim Based on FDCA Preemption | McDermott Will & Emery - Vimarsana News

Can't Dismiss Lanham Act Claim Based on FDCA Preemption | McDermott Will & Emery

The US Court of Appeals for the First Circuit affirmed-in-part and vacated-in-part a district court ruling dismissing claims under the Lanham Act and Massachusetts consumer protection...

1st Circ. Partially Resurrects Azurity's Beef With Edge Pharma - Vimarsana News

1st Circ. Partially Resurrects Azurity's Beef With Edge Pharma

The First Circuit on Friday partially revived portions of Azurity Pharmaceuticals' suit against Edge Pharma over its competing hydrochloride vancomycin drug, agreeing with a Massachusetts federal court that some of its claims don't hold up, but not for the same reason.  

Source: law360.com
A Vermont Drug Company's Failure to Maintain Standards Led to Recalls — and its Demise - Vimarsana News

A Vermont Drug Company's Failure to Maintain Standards Led to Recalls — and its Demise

A Vermont pharmaceutical company with a history of defying safety regulations closed last month amid mounting pressure from federal inspectors who accused it of selling...

Edge Pharma of Colchester signs agreement with Justice Department - Vimarsana News

Edge Pharma of Colchester signs agreement with Justice Department

The United States alleged that inspections revealed record-keeping violations, labelling inadequacies, improper airflow, disrepair and mold.

Compounding pharmacy agrees to stop distributing some drugs - Vimarsana News

Compounding pharmacy agrees to stop distributing some drugs

The U.S. Justice Department says a Vermont compounding pharmacy has agreed to stop producing adulterated and misbranded drugs

Source: go.com